Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Course of Antenatal Corticosteroids in PPROM
NCT02939742Phase 3Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Nov 2016
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial in preterm premature rupture of membranes (pPROM) comparing Betamethasone with Saline Placebo (2 arms). Primary endpoint: Average Number of Days in the Neonatal Intensive Care Unit (NICU) up to 1 year. Started Nov 2016; status: terminated.
02
Drugs
betamethasone
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT02939742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939742.